Genomics NHS Flashcards
1
Q
Main techniques and example of application?
A
- PCR (QF, RT, triplet), Haemophilia A
- karyotyping, structural rearrangements, AML
- pyrosequencing, EDS, OI
- arrays (microarrays, CGH, SNP, methylation), fragile X
- sequencing (panels, WES, WGS), Wilson disease
- FISH, PWS, ALL
- MLPA, BWS
- NIPD, CF
2
Q
Types of PCR used, and application?
A
- QF-PCR = for common aneuploidies (13/18/21/X), on fetal tissue samples (amnio/CV) or blood samples from newborns
- RT-PCR = specific AML inversions
- triplet PCR = for repeat expansions, eg. HD
- STR analysis = STR regions of DNA extracted and amp to find no. repeats of these variable seqs
3
Q
Applications of karyotyping?
A
- poss structural rearrangement or chromosomal mosaicism
- ambiguous genitalia –> sex chromosome karyotype
- aneuploidies –> eg. Down’s Syndrome (trisomy 21), Turner Syndrome (XO), Patau Syndrome (trisomy 13)
- AML –> for structural variant detection and copy number variant detection
4
Q
How does pyrosequencing work?
A
- DNA broken up into 100bp ss fragments
- PCR creates millions of copies of each fragment, split across thousands of wells, with just one type of fragment per well
- DNA fragments incubated with DNA pol, ATP sulfurylase, and apyrase enzymes, and adenosine 5’ phosphosulfate and luciferin substrates.
- 1 type of nts added to wells and incorp by DNA pol at 3’ end, releasing pyrophosphate, ATP sulfurylase converts this to ATP, which takes part in the luciferase-mediated conversion of luciferin to oxyluciferin, thus emitting light proportional to amount of ATP, which is picked up by a detector
- unused nucleotides and ATP degrade to apyrase, allowing the reaction to start again with another nucleotide, process is repeated, adding each nucleotide until the synthesis is complete
- detector picks up the intensity of light emitted, used to infer the number and type of nucleotides added
5
Q
Applications of pyrosequencing?
A
- for connective tissue disorders, eg. EDS = heterogenous group of disorders, investigate for vascular/classical dependant on presenting symptoms as underlying genes varies
- osteogenesis imperfecta (autosomal dominant and recessive) –> 90% patients have defect in type I collagen and usually inherited autosomally dominantly, but severe OI often result of de novo mutation (can also get parental mosaicism causing familial recurrence)
- oncology: eg. non-Hodgkin’s Lymphoma, Ig gene and rearrangement and hypermutation detection
6
Q
Types of arrays and applications?
A
- microarrays , eg. for intellectual disabilities like fragile X –> method: denature DNA, fragment DNA, label each fragment w/ fluorescent dye, sample and control DNA labelled w/ diff colours, both sets of DNA inserted into chip and allowed to hybridise to synthetic DNA on chip, if there is a mutation, sample DNA won’t bind correctly to normal sequence on chip, but will bind sequence representing mutated DNA
- CGH (comparative genomic hybridisation) arrays = microarray, for analysing CNVs relative to ploidy levels in sample comp to reference, w/o need to culture cells –> used for prenatal stuff
- SNP arrays, eg. ALL, for analysing CNVs, similar to CGH but also look at loss of heterozygosity (looking to switch to these completely)
- methylation arrays for some pediatric tumours and some neurological tumours (CpG sites) –> DNA methylation at promoters reduces gene expression
- methylation Testing (constitutional) → PWS/AS critical region for Prader Willi and Angelman
7
Q
Advantage of arrays over sequencing?
A
- low cost and high throughput
8
Q
Types of sequencing and applications?
A
- small, medium or large panels depending on disease/area looking at mutations
- Wilson disease = bi-directional sequencing of whole protein coding region identifies 99.9% of disease alleles
- Haemophilia A = sequencing of protein coding region detects over 90% disease alleles in those negative for inversions with moderate/severe disease
- single gene sequencing, eg. factor X deficiency
- WES, eg. glycogen storage disease (metabolic disorder) = more targeted, so cheaper and can return results quicker, most disease causing variants thought to be in exomes
- WGS, eg. neonatal diabetes = can look at SNVs, indels, SV and CNVs, includes promoters and enhancers unlike WES
9
Q
How does FISH work?
A
- helps identify where particular gene falls w/in individuals chromosomes
- method: prepare short seqs of ssDNA matching gene looking for (=probes), label probes w/ fluorescent dye, will bind complementary DNA when added, so location of fluorescence shows gene
- types of probe: locus specific, centromeric repeat, whole chrom probes
- largely replaced by microarrays for many apps
10
Q
Applications of FISH?
A
- constitutional, eg. Prader-Willi microdeletion/microduplication
- oncology, eg. for AFF1/MLL dual fusion (acute lymphoblastic leukemia), BCL2 breakapart (B cell lymphoma 2)
11
Q
What is MLPA and applications?
A
- variation of PCR that allows amp of multiple targets w/ single primer pair
- can detect CNVs in whole chroms to single exons
- haemophilia A = in some testing for exon duplications/deletions is appropriate using MLPA
- BWS = 11p15 growth imprinted region
12
Q
What is NIPD and applications?
A
- by CV/amnio
- works by analysing cfDNA in mothers blood (most is from mothers cells, but some from placenta will contain fetal DNA (cffDNA = cell-free fetal DNA)
- haplotype testing for CF and BMD/DMD
- haplotype = set of mutations/polymorphisms that tend to be inherited together
- Rhesus testing
13
Q
Example of autosomal dominant and testing?
A
- Huntington’s (HTT) = STR for those w/ clinical indications, or linkage analysis for families w/ confirmed diagnosis
- Osteogenesis Imperfecta (usually AD) = WES or medium panel of genes/loci
14
Q
Example of autosomal recessive and testing?
A
- CF (CFTR) = NIPD by haplotype testing or mutation testing when parents are carriers, or for child w/ suspected CF can do targeted mutation testing, single gene sequencing or MLPA, carrier testing also by targeted mutation testing
15
Q
Example of X-linked dominant and testing?
A
- Fragile X (FMR1) = STR testing, microarrays for intellectual disabilities overlap